Kyle Martin Flickinger, Deep Lens

Kyle Martin Flickinger Kyle leads the strategy for Deep Lens Bio Pharmaceutical solutions with a laser-focused mission to identify and collaborate with game changers who want to speed precision diagnosis, treatment options, and hope. He is an industry innovator focused on developing solutions and businesses at the intersection of healthcare delivery & research, to drive better outcomes for patients. For over 20 years Kyle has brought a passion and belief that meaningful change is possible across a diverse set of health system stakeholders by humbly challenging the status quo. Recently Kyle was the Executive Director of Care Coordination Solutions at ProMetrics (A Concerto Health AI company) where he led efforts to develop a next-gen Care Coordination Solution for specialty brand teams in oncology. The solution integrated various tools to put patients into the center of their therapy journey with prescribers, specialty pharmacies, hubs, and patient assistance programs. Most notably Kyle was a key innovation leader at Parexel having created the role from the acquisition of DataLabs EDC and ClinPhone in 2004 where he led global professional services. At Parexel he was responsible for defining and positioning new eClinical solutions across SBU’s and to the market garnering internal and external advocates. He subsequently became an established “voice of value” where he led many high profile clients focused on digital health strategies, which resulted in key study/program collaborations, and acquisitions. Additionally, Kyle was a Vice President with HealthVerity leading efforts to utilize a next-gen healthcare data marketplace to link clinical trial data at the patient level with other real-world data to drive efficiencies in HEOR, Med affairs, and clinical study design.


4:25 PM - 5:00 PM

Innovation Spotlight Changemaker Presentations

The Innovation Spotlight Presentation program features six changemaker speakers along with moderator Travis McCready, President & CEO of Massachusetts Life Sciences Center. Each speaker presents a concise and fast-paced 5-minute presentation that will introduce you to an innovative way of solving a problem, a new technology or tool, or a transformative approach to solving common issues facing biopharma companies today. Immediately following the spotlight presentations, attendees can meet with these innovative companies in a relaxed atmosphere during the evening reception.


Changemaker Presenters

  • Ijah Mondesire-Crump, MD

    Ijah Mondesire-Crump, MD Director of Clinical Research nQ Medical, Inc.

    • Organizations must recognize barriers to adoption of digital health. Proprietary devices and task-based apps are inversely proportional to patient adoption.
    • Target “people” and not just patients.
    • Digital health products must be built on tomorrow’s healthcare system, not today’s.


  • Kyle Martin Flickinger

    Kyle Martin Flickinger Vice President Bio Pharmaceutical Solution Strategy Deep Lens

    • Speed to Hope – What does confirmation of diagnosis in precision oncology really imply?
    • The use of digital pathology case management workflow and AI to support clinical research as a care option:
        – What is the need? What are the solutions? Where is Digital pathology heading?


  • Tim Gardner, Ph.D.

    Tim Gardner, Ph.D. Founder/CEO Riffyn

    Lab data to machine learning in 30 seconds

    • Lab challenge: data heterogeneity, silos, constant change in R&D
    • Data challenge: systems lack structure, flexibility, accessibility
    • Solution: evolvable “scientific blueprints”: bridge silos with clean & connected data
  • David Wild, Ph.D.

    David Wild, Ph.D. Founder & President Data2Discovery Inc

    • Data2Discovery is applying AI in drug discovery and decreasing the process from 6 years to 6 weeks!
    • By using target identification methods and a disease-driven approach to find new therapies, the cost it takes to bring a drug to market is significantly reduced.
    • David will discuss Use Case examples which address: 1) the business problem of finding new leads as quickly as possible for an ROI, and 2) how the importance of understanding the disease and the intricate biological
      relationships in the data is crucial.

Download Latest Agenda